CHAVEZ R. MARTIN
Insider CIK 1157983 · RXRX Director · GOOGL Director · GS Executive Vice President - CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GOOGL Alphabet Inc. | A Award | 2026-09-14 | 2026-09-16 | 1 | — | $0 | 903 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2026-09-14 | 2026-09-16 | 1 | — | $0 | 1,433 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2026-09-14 | 2026-09-16 | 1 | — | $0 | 941 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2026-09-14 | 2026-09-16 | 0 | — | $0 | 597 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2026-09-14 | 2026-09-16 | 1 | — | $0 | 941 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2026-09-14 | 2026-09-16 | 1 | — | $0 | 1,433 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2026-09-14 | 2026-09-16 | 1 | — | $0 | 903 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2026-09-14 | 2026-09-16 | 0 | — | $0 | 597 | SEC↗ |
| GOOGL Alphabet Inc. | G Gift | 2026-09-01 | 2026-09-03 | 1,181 | — | $0 | 9,989 | SEC↗ |
| GOOGL Alphabet Inc. | G Gift | 2026-09-01 | 2026-09-03 | 1,181 | — | $0 | 9,989 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2026-07-01 | 2026-07-06 | 980 | — | $0 | 980 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2026-06-15 | 2026-06-17 | 0 | — | $0 | 371 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2026-06-15 | 2026-06-17 | 1 | — | $0 | 777 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2026-06-15 | 2026-06-17 | 1 | — | $0 | 1,026 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2026-06-15 | 2026-06-17 | 1 | — | $0 | 1,558 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2026-03-16 | 2026-03-18 | 1 | — | $0 | 955 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2026-03-16 | 2026-03-18 | 1 | — | $0 | 1,684 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2026-03-16 | 2026-03-18 | 1 | — | $0 | 927 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2026-03-16 | 2026-03-18 | 1 | — | $0 | 1,148 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2025-12-15 | 2025-12-17 | 1 | — | $0 | 1,133 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2025-12-15 | 2025-12-17 | 1 | — | $0 | 1,270 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2025-12-15 | 2025-12-17 | 1 | — | $0 | 1,809 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2025-12-15 | 2025-12-17 | 1 | — | $0 | 1,482 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2025-09-15 | 2025-09-17 | 2 | — | $0 | 1,934 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2025-09-15 | 2025-09-17 | 2 | — | $0 | 2,036 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2025-09-15 | 2025-09-17 | 1 | — | $0 | 1,312 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2025-09-15 | 2025-09-17 | 1 | — | $0 | 1,392 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2025-07-02 | 2025-07-11 | 2,016 | — | $0 | 2,016 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2025-06-16 | 2025-06-18 | 2 | — | $0 | 1,513 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2025-06-16 | 2025-06-18 | 2 | — | $0 | 1,489 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2025-06-16 | 2025-06-18 | 3 | — | $0 | 2,589 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2025-03-17 | 2025-03-18 | 2 | — | $0 | 1,666 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2025-03-17 | 2025-03-18 | 2 | — | $0 | 1,634 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2025-03-17 | 2025-03-18 | 4 | — | $0 | 3,140 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2024-12-16 | 2024-12-17 | 4 | — | $0 | 3,689 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2024-12-16 | 2024-12-17 | 2 | — | $0 | 1,754 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2024-12-16 | 2024-12-17 | 2 | — | $0 | 1,841 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2024-09-16 | 2024-09-18 | 5 | — | $0 | 4,239 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2024-09-16 | 2024-09-18 | 3 | — | $0 | 2,018 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2024-09-16 | 2024-09-18 | 2 | — | $0 | 1,874 | SEC↗ |
| GOOGL Alphabet Inc. | A Award | 2024-07-03 | 2024-07-05 | 1,953 | — | $0 | 1,953 | SEC↗ |
| GOOG Alphabet Inc. | A Award | 2024-06-17 | 2024-06-18 | 5 | — | $0 | 4,785 | SEC↗ |
| GOOG Alphabet Inc. | A Award | 2024-06-17 | 2024-06-18 | 2 | — | $0 | 2,192 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-04-01 | 2024-04-03 | 2,001 | — | $0 | 60,078 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-01-02 | 2024-01-04 | 1,900 | — | $0 | 58,077 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2023-10-02 | 2023-10-04 | 2,619 | — | $0 | 56,177 | SEC↗ |
| GOOG Alphabet Inc. | A Award | 2023-07-05 | 2023-07-06 | 2,841 | — | $0 | 2,841 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2023-07-03 | 2023-07-06 | 2,541 | — | $0 | 53,558 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2023-06-16 | 2023-06-21 | 25,224 | — | $0 | 25,224 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2023-06-16 | 2023-06-21 | 12,612 | — | $0 | 51,017 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2023-04-03 | 2023-04-05 | 2,721 | — | $0 | 38,405 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2023-01-03 | 2023-01-05 | 2,483 | — | $0 | 35,684 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-10-03 | 2022-10-05 | 1,725 | — | $0 | 33,201 | SEC↗ |
| GOOG Alphabet Inc. | A Award | 2022-08-03 | 2022-08-09 | 8,824 | — | $0 | 8,824 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-07-01 | 2022-07-06 | 2,224 | — | $0 | 31,476 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2022-06-14 | 2022-06-16 | 36,290 | — | $0 | 36,290 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-06-14 | 2022-06-16 | 18,145 | — | $0 | 29,252 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-04-01 | 2022-04-05 | 2,438 | — | $0 | 11,107 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-01-03 | 2022-01-05 | 1,040 | — | $0 | 8,669 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2021-10-01 | 2021-10-05 | 858 | — | $0 | 7,629 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2021-07-01 | 2021-07-06 | 521 | — | $0 | 6,771 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 12,500 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 525,000 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 525,000 | — | $0 | 525,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion | 2021-04-20 | 2021-04-22 | 6,250 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion | 2021-04-20 | 2021-04-22 | 6,250 | — | $0 | 6,250 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2021-04-16 | 2021-04-19 | 6,250 | — | $0 | 6,250 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2021-04-15 | 2021-04-19 | 12,500 | — | $0 | 12,500 | SEC↗ |
| GS GOLDMAN SACHS GROUP INC | S Sale | 2018-02-07 | 2018-02-09 | 2,656 | $260.44 | $691.7K | 77,129 | SEC↗ |
| GS GOLDMAN SACHS GROUP INC | S Sale | 2018-02-07 | 2018-02-09 | 540 | $257.39 | $139.0K | 1,000 | SEC↗ |
| GS GOLDMAN SACHS GROUP INC | S Sale | 2018-02-07 | 2018-02-09 | 500 | $259.26 | $129.6K | 500 | SEC↗ |
| GS GOLDMAN SACHS GROUP INC | S Sale | 2018-02-07 | 2018-02-09 | 500 | $260.43 | $130.2K | 0 | SEC↗ |
| GS GOLDMAN SACHS GROUP INC | S Sale | 2018-02-07 | 2018-02-09 | 1,575 | $257.46 | $405.5K | 85,543 | SEC↗ |
| GS GOLDMAN SACHS GROUP INC | S Sale | 2018-02-07 | 2018-02-09 | 3,958 | $259.44 | $1.03M | 79,785 | SEC↗ |
| GS GOLDMAN SACHS GROUP INC | S Sale | 2018-02-07 | 2018-02-09 | 1,800 | $258.38 | $465.1K | 83,743 | SEC↗ |
| GS GOLDMAN SACHS GROUP INC | S Sale | 2018-02-07 | 2018-02-09 | 300 | $261.27 | $78.4K | 76,829 | SEC↗ |
| GS GOLDMAN SACHS GROUP INC | S Sale | 2018-01-31 | 2018-02-02 | 3,164 | $269.72 | $853.4K | 87,118 | SEC↗ |
| GS GOLDMAN SACHS GROUP INC | S Sale | 2018-01-31 | 2018-02-02 | 200 | $266.96 | $53.4K | 2,880 | SEC↗ |
| GS GOLDMAN SACHS GROUP INC | S Sale | 2018-01-31 | 2018-02-02 | 540 | $268.45 | $145.0K | 2,340 | SEC↗ |
| GS GOLDMAN SACHS GROUP INC | S Sale | 2018-01-31 | 2018-02-02 | 800 | $269.53 | $215.6K | 1,540 | SEC↗ |
| GS GOLDMAN SACHS GROUP INC | S Sale | 2018-01-31 | 2018-02-02 | 1,543 | $267.01 | $412.0K | 95,864 | SEC↗ |
| GS GOLDMAN SACHS GROUP INC | S Sale | 2018-01-31 | 2018-02-02 | 2,108 | $268.14 | $565.2K | 93,756 | SEC↗ |
| GS GOLDMAN SACHS GROUP INC | S Sale | 2018-01-31 | 2018-02-02 | 3,474 | $268.92 | $934.2K | 90,282 | SEC↗ |
| GS GOLDMAN SACHS GROUP INC | M Exercise deriv | 2017-12-28 | 2017-12-29 | 58,108 | — | $0 | 0 | SEC↗ |
| GS GOLDMAN SACHS GROUP INC | M Exercise | 2017-12-28 | 2017-12-29 | 58,108 | — | $0 | 129,842 | SEC↗ |
| GS GOLDMAN SACHS GROUP INC | F Tax w/h | 2017-12-28 | 2017-12-29 | 32,435 | $255.95 | $8.30M | 97,407 | SEC↗ |